[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB1198283A - Novel Sydnonimine Derivatives, the preparation thereof and Compositions containing the same - Google Patents

Novel Sydnonimine Derivatives, the preparation thereof and Compositions containing the same

Info

Publication number
GB1198283A
GB1198283A GB35049/67A GB3504967A GB1198283A GB 1198283 A GB1198283 A GB 1198283A GB 35049/67 A GB35049/67 A GB 35049/67A GB 3504967 A GB3504967 A GB 3504967A GB 1198283 A GB1198283 A GB 1198283A
Authority
GB
United Kingdom
Prior art keywords
group
alkyl
formula
general formula
sydnonimine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB35049/67A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Boehringer Ingelheim GmbH
Original Assignee
CH Boehringer Sohn AG and Co KG
Boehringer Ingelheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG, Boehringer Ingelheim GmbH filed Critical CH Boehringer Sohn AG and Co KG
Publication of GB1198283A publication Critical patent/GB1198283A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB35049/67A 1966-08-09 1967-07-31 Novel Sydnonimine Derivatives, the preparation thereof and Compositions containing the same Expired GB1198283A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB0088408 1966-08-09

Publications (1)

Publication Number Publication Date
GB1198283A true GB1198283A (en) 1970-07-08

Family

ID=6984280

Family Applications (1)

Application Number Title Priority Date Filing Date
GB35049/67A Expired GB1198283A (en) 1966-08-09 1967-07-31 Novel Sydnonimine Derivatives, the preparation thereof and Compositions containing the same

Country Status (16)

Country Link
JP (1) JPS537433B1 (de)
BE (1) BE702448A (de)
BG (1) BG15571A3 (de)
CA (1) CA925083A (de)
CH (1) CH507277A (de)
DE (1) DE1670127A1 (de)
DK (1) DK126594B (de)
ES (1) ES343818A1 (de)
FI (1) FI49420C (de)
FR (2) FR1551013A (de)
GB (1) GB1198283A (de)
IL (1) IL28432A (de)
NL (1) NL153195B (de)
PH (1) PH10178A (de)
SE (1) SE343304B (de)
YU (1) YU34691B (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006540A (en) * 1988-11-03 1991-04-09 Cassella Aktiengesellschaft Substituted 3-aminosydnonimines, processes for their preparation and their use
US5179206A (en) * 1989-07-03 1993-01-12 Cassella Aktiengellschaft Substituted 3-aminosydnone imines

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2930736A1 (de) * 1979-07-28 1981-02-12 Cassella Ag Pharmakologisch wirksame, substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE3921460A1 (de) * 1989-06-30 1991-01-03 Cassella Ag Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE4025604A1 (de) * 1990-08-13 1992-02-20 Cassella Ag 3-dicyclohexylamino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE4028679A1 (de) * 1990-09-10 1992-03-19 Cassella Ag Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung
AU3632393A (en) * 1992-03-24 1993-10-21 Cassella Aktiengesellschaft Use of sydnonimines to treat erectile dysfunction
DE4337335A1 (de) * 1993-11-02 1995-05-04 Cassella Ag Verfahren zur Herstellung von Sydnoniminium-hydrogensulfaten

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006540A (en) * 1988-11-03 1991-04-09 Cassella Aktiengesellschaft Substituted 3-aminosydnonimines, processes for their preparation and their use
US5179206A (en) * 1989-07-03 1993-01-12 Cassella Aktiengellschaft Substituted 3-aminosydnone imines

Also Published As

Publication number Publication date
DE1670127A1 (de) 1970-12-03
IL28432A (en) 1972-01-27
FI49420B (de) 1975-02-28
NL6710945A (de) 1968-02-12
BG15571A3 (bg) 1976-06-21
FR1551013A (de) 1968-12-27
SE343304B (sv) 1972-03-06
BE702448A (de) 1968-02-08
CA925083A (en) 1973-04-24
YU156567A (en) 1979-07-10
NL153195B (nl) 1977-05-16
PH10178A (en) 1976-09-16
YU34691B (en) 1979-12-31
FI49420C (fi) 1975-06-10
FR8428M (de) 1971-07-08
DK126594B (da) 1973-07-30
CH507277A (de) 1971-05-15
ES343818A1 (es) 1968-12-01
JPS537433B1 (de) 1978-03-17

Similar Documents

Publication Publication Date Title
MY101541A (en) Indolizine derivatives, process for preparing them and the compositions containing them
DE69230163D1 (de) Thiazolylbenzofuranderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
RU92004336A (ru) Водорастворимые производные камптотецина, способ их получения, фармацевтическая композиция, способ ингибирования энзима топоизомеразы, промежуточные продукты
NO163855C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylcyklobutylalkylaminer.
FR2669927B1 (fr) Nouveaux derives de guanidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
GB1198283A (en) Novel Sydnonimine Derivatives, the preparation thereof and Compositions containing the same
GB1181673A (en) Derivatives of Xanthen and Thiaxanthen and Preparation Thereof
SE8206282L (sv) Ergolinderivat och forfarande for deras framstellning samt farmaceutiska kompositioner der de ingar
DE3889987D1 (de) N-[(2-Oxopyrrolidin-1-yl)acetyl]piperazin-Derivate und Arzneimittel gegen senile Dementia.
GB1260768A (en) N-alkyl-tetrahydrocarbazoles
GB1367785A (en) 2-substituted adenosine derivatives and the production thereof
GB1178242A (en) Novel Biologically Active Bis-Isothioureas
FR2653123B1 (fr) Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
FR2681864B1 (fr) Nouveaux derives bicycliques azotes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
GB1342321A (en) Nitrofuran derivatives
DE69110217D1 (de) Derivate der Kaffeinsäure und sie enthaltende pharmazeutische Zusammensetzungen.
GB1198459A (en) Substituted 2-Amino and 2-Nitrobenzamides and preparation thereof
ES8304133A1 (es) "procedimiento para preparar nuevos derivados de triazoloquinazolinona".
GB1156781A (en) New Heterocyclic Compounds
GB1403841A (en) Imidazo heterocyclic derivatives
CA2140781A1 (en) Pharmocologically active .alpha.-¬tertiary-aminomethyl|- benzenemethanol derivatives
GB1353486A (en) Benzodiazepine derivatives
GB1254270A (en) Benzoxazepine derivatives
ES358442A1 (es) Procedimiento de preparacion de 1h-2, 3-benzoxazinas.
SE8000699L (sv) Nya kinazolinderivat jemte sett for deras framstellning och farmaceutiska beredningar innehallande dem

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE20 Patent expired after termination of 20 years